Combined chemotherapy and radiation therapy in surgically unresectable regionally advanced non-small cell lung cancer

Seminars in Radiation Oncology

Volumn 6, Issue 2, 1996, Pages 86-91

  Komaki, R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; HUMAN; LUNG NON SMALL CELL CANCER; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; REVIEW; SURGICAL RISK; TREATMENT OUTCOME;

EID: 0030000523     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-4296(96)80004-X     Document Type: Article

References (32)

1. 1995 Cancer Facts and Fictures 1995 American Cancer Society Atlanta, GA
2. Mountain CF A new international staging system for lung cancer Chest 89 1986 225S 233S
3. Dillman RO Seagren SL Propert KJ A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III nonsmall cell lung cancer N Engl J Med 323 1990 940 945
4. Green MR Lilenbaum RC Stage IIIA category of nonsmall cell lung cancer: A new proposal J Natl Cancer Inst 86 1994 586 588
5. Martini N Flehinger BJ The role of surgery in N2 lung cancer Surg Clin North Am 67 1987 1037 1049
6. Begg AC Hofland I van Glabekke M Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: Results from the EORTC cooperative trial 22851 Semin Radiat Oncol 2 1992 22 25
7. Horiot JC Le Fur R Schraub S Status of the experience of the EORTC cooperative group of radiotherapy with hyperfractionated and acclerated radiotherapy regimes Semin Radiat Oncol 2 1992 34 37
8. Slebos RJC Kibbelaar RE Dalesio O K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung N Engl J Med 323 1990 561 565
9. Bauer M Birch R Pajak TF Prognostic factors in cancer of the lung Cox JD Syllabus: A Categorical Course in Radiation Therapy: Lung Cancer 1985 Radiological Society of North America Oak Brook, IL
10. Cox JD Azarnia N Byhardt RW A randomized phase I/II trial of hyperfractionated radiation therapy with total dose of 60.0 Gy to 79.2 Gy: Possible survival benefit with ≥69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III nonsmall cell carcinoma of the lung. Report of RTOG83-11 J Clin Oncol 8 1990 1543 1555
11. Mountain CF Surgery for Stage IIIA-N2 nonsmall cell lung cancer Cancer 73 1994 2589
12. Watanabe Y Shimizu J Oda M Aggressive surgical intervention in N2 nonsmall cell cancer of the lung Ann Thorac Surg 51 1991 523 561
13. Maggi G Casadio C Mancuso M Resection and radical lymphadenectomy for lung cancer: Prognostic significance of lymphatic metastases Int Surg 75 1990 17 21
14. Perez CA Stanley K Rubin P A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group Cancer 45 1980 2744 2753
15. Dillman RO Seagren SL Herndon J Randomized trial of induction chemotherapy plus radiation therapy vs. radiation therapy alone in stage III nonsmall cell lung cancer: Five-year follow-up of CALGB 84-33 Proc Am Soc Clin Oncol 12 1993 329
16. Le Chevalier T Arriagada R Quoix E Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable nonsmall cell lung carcinoma Lung Cancer 10 1994 S239 S252
17. Sause WT Scott C Taylor S Radiation Therapy Oncology Group 88-08 and Eastern Cooperative Oncology Group 4588: Preliminary results of a phase III trial in regionally advanced, unresectable nonsmall cell lung cancer J Natl Cancer Inst 87 1995 198 205
18. Schaake-Koning C van den Bogaert W Dalcsio O Effects of concomitant cisplatin and radiotherapy on inoperable nonsmall cell lung cancer N Engl J Med 326 1992 524 530
19. Wolf M Hans K Becker H Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced nonsmall cell lung cancer Semin Oncol 21 1994 42 47
20. Trovo MG Minatel E Veronesi A Combined radiotherapy and chemotherapy versus radiotherapy alone in locally advanced epidermoid bronchogenic carcinoma. A randomized study Cancer 65 1990 400 404
21. Morton RF Jett JR McGinnis I Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable nonsmall cell lung cancer Ann Intern Med 115 1991 681 686
22. Mattson K Holsti L Holsti P Inoperable nonsmall cell lung cancer: Radiation with or without chemotherapy Eur J Clin Oncol 24 1988 477 482
23. Ansari R Tokars R Fisher W A phase III study of thoracic irradiation with or without concomitant cisplatin in locoregional unresectable nonsmall cell cancer: A Hoosier Oncology Group Protocol Proc Am Soc Clin Oncol 10 1991 241
24. Robinow JS Shaw EG Eagan RT Results of combination chemotherapy and thoracic radiation therapy for unresectable nonsmall cell carcinoma of the lung Int J Radiat Oncol Biol Phys 17 1989 1203 1210
25. Lee JS Scott C Komaki R Concurrent chemoradiation therapy with oral VP-16 and cisplatin for locally advanced inoperable nonsmall cell lung cancer: RTOG protocol 91-06 Proc Am Soc Clin Oncol 13 1994 363
26. Albain K Rusch V Crawley J Concurrent cisplatin/ctoposide and chest radiation followed by surgery for stage 3A and 3B nonsmall cell lung cancer. Completed analysis of SWOG 8805 Proc Am Soc Clin Oncol 13 1994 337
27. Jeremic B Jevremovic S Mijatovic L Hyperfractionated radiation therapy with and without concurrent chemotherapy for advanced nonsmall cell lung cancer Cancer 71 1993 3732 3736
28. Lilienbaum RC Green MR Novel chemotherapeutic agents in the treatment of nonsmall cell lung cancer J Clin Oncol 11 1993 1391 1402
29. Murphy WK Fossella FV Winn RJ Phase II study of taxol in patients with untreated advanced nonsmall cell lung cancer J Natl Cancer Inst 85 1993 384 387
30. Schiff PB Fant J Horwitz SB Promotion of microtubule assembly in vitro by Taxol Nature 277 1979 665 667
31. Fukuoka M Niitani H Suzuki A A phase II study of CPT11, a new derivative of camptothecin for previously untreated nonsmall cell lung cancer J Clin Oncol 10 1992 16 21
32. Graham MV Jahanzeb M Dresler C Preliminary results of a phase I study of topotecan plus thoracic radiotherapy for locally advanced nonsmall cell lung cancer Proc Am Soc Clin Oncol 13 1994 340